Masanao Yokohira

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Keiko Yamakawa · 3 shared papers, 2019–2021 · strength 0.34
   • Paper Development and Clinical Trials of Nucleic Acid Medicines for Pancreatic Cancer Treatment. DOI 10.3390/ijms20174224↗
   • Paper Adequate tissue sampling for the assessment of pathological tumor regression in pancreatic cancer. DOI 10.1038/s41598-021-86152-y↗
   • Paper Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreati… DOI 10.1016/j.pan.2021.09.006↗
2. Yoko Matsuda · 3 shared papers, 2019–2021 · strength 0.34
   • Paper Development and Clinical Trials of Nucleic Acid Medicines for Pancreatic Cancer Treatment. DOI 10.3390/ijms20174224↗
   • Paper Adequate tissue sampling for the assessment of pathological tumor regression in pancreatic cancer. DOI 10.1038/s41598-021-86152-y↗
   • Paper Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreati… DOI 10.1016/j.pan.2021.09.006↗
3. Juanjuan Ye · 2 shared papers, 2021 · strength 0.22
   • Paper Adequate tissue sampling for the assessment of pathological tumor regression in pancreatic cancer. DOI 10.1038/s41598-021-86152-y↗
   • Paper Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreati… DOI 10.1016/j.pan.2021.09.006↗
4. Motohiro Kojima · 2 shared papers, 2021 · strength 0.22
   • Paper Adequate tissue sampling for the assessment of pathological tumor regression in pancreatic cancer. DOI 10.1038/s41598-021-86152-y↗
   • Paper Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreati… DOI 10.1016/j.pan.2021.09.006↗
5. Yasuyuki Suzuki · 2 shared papers, 2021 · strength 0.22
   • Paper Adequate tissue sampling for the assessment of pathological tumor regression in pancreatic cancer. DOI 10.1038/s41598-021-86152-y↗
   • Paper Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreati… DOI 10.1016/j.pan.2021.09.006↗
6. Keiichi Okano · 2 shared papers, 2021 · strength 0.22
   • Paper Adequate tissue sampling for the assessment of pathological tumor regression in pancreatic cancer. DOI 10.1038/s41598-021-86152-y↗
   • Paper Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreati… DOI 10.1016/j.pan.2021.09.006↗
7. Minoru Oshima · 1 shared paper, 2021 · strength 0.12
   • Paper Adequate tissue sampling for the assessment of pathological tumor regression in pancreatic cancer. DOI 10.1038/s41598-021-86152-y↗
8. Kenichi Hirabayashi · 1 shared paper, 2021 · strength 0.12
   • Paper Adequate tissue sampling for the assessment of pathological tumor regression in pancreatic cancer. DOI 10.1038/s41598-021-86152-y↗
9. Ai Kameyama · 1 shared paper, 2021 · strength 0.10
   • Paper Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreati… DOI 10.1016/j.pan.2021.09.006↗
10. Ayaka Shimomura · 1 shared paper, 2021 · strength 0.10
    • Paper Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreati… DOI 10.1016/j.pan.2021.09.006↗
11. Mutsuo Furihata · 1 shared paper, 2021 · strength 0.10
    • Paper Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreati… DOI 10.1016/j.pan.2021.09.006↗
12. Mari A. Mino-Kenudson · 1 shared paper, 2021 · strength 0.10
    • Paper Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreati… DOI 10.1016/j.pan.2021.09.006↗
13. Chiharu Tanaka · 1 shared paper, 2021 · strength 0.10
    • Paper Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreati… DOI 10.1016/j.pan.2021.09.006↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.